Vaccines and allergy;Vaccinations et allergie

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 47, Issue 1, 2007, Pages 9-15

  Ponvert, C ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Allergy; Atopy; Diagnostic; Prevention; Vaccines

Indexed keywords

ALLERGEN; ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; PROTEIN; VACCINE;

ALLERGIC REACTION; ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY DETECTION; ASTHMA; ATOPIC DERMATITIS; ATOPY; BRONCHUS HYPERREACTIVITY; CHRONOLOGY; DRUG TOLERABILITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PREDICTION; REVIEW; SKIN TEST; URTICARIA; VACCINATION;

EID: 33847261105     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.allerg.2006.12.003     Document Type: Review

References (81)

1. Aukrust L., Almeland T.L., Refsum D., and Aas K. Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Allergy 35 (1980) 581
2. Baxter D.N. Measles immunization in children with a history of egg allergy. Vaccine 14 (1996) 131-134
3. Beck S., Williams L.W., Shirrell M.A., and Burks A.W. Egg hypersentitivity and measles-mumps-rubella vaccine administration. Pediatrics 88 (1991) 913-917
4. Fasano M.B., Wood R.A., Cooke S.K., and Sampson H.A. Egg hypersensitivity and adverse reactions to measles, mumps and rubella vaccine. J Pediatr 120 (1992) 878-881
5. Herman J.J., Radin R., and Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 102 (1983) 196-199
6. Vourga V., Tapratzi P., and Panayatopoulou K. Measles-mumps-rubella vaccine (MMR) in egg-allergic children. Allergy 52 (1997) 96
7. Lavi S., Zimmermann B., Koren G., and Gold R. Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. J Am Med Assn 263 (1990) 269-271
8. Bidat E., and Rancé F. Vaccination et allergie à l'œuf. Arch Pediatr 11 (2004) 460-461
9. Eigenmann P. Allergie à l'œuf : state of the art. Rev Fr Allergol Immunol Clin 43 (2003) 450-454
10. Khakoo G.A., and Lack G. Guidelines for measles vaccination in egg-allergic children. Clin Exp Allergy 30 (2000) 288-293
11. Lakshman R., and Finn A. MMR vaccine and allergy. Arch Dis Child 82 (1999) 93-97
12. Patja A., Makinen-Kiljunen S., Davidkin I., Paunio M., and Peltola H. Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 107 (2001) e27-e34
13. Kelso J.M., Jones R.T., and Yunginger J.W. Anaphylaxis to measles, mumps and rubella vaccine mediated by IgE to gelatin. J Allergy Clin Immunol 91 (1993) 867-872
14. Kumagai T., Yamanaka T., Wataya Y., Umetsu A., Kawamura N., Ikeda K., et al. Gelatin-specific humoral and cellular immune responses in children with immediate- and non immediate-type reactions to live measles, mumps, rubella and varicella vaccines. J Allergy Clin Immunol 30 (1997) 1430-1435
15. Sissman N.J. Allergic reactions to MMR vaccine. Pediatrics 88 (1992) 168-169
16. Sakaguchi M., Nakayama T., and Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J Allergy Clin Immunol 98 (1996) 1058-1061
17. Sakaguchi M., Yoshida M., Kuroda W., Harayama O., Matsunaga Y., and Inouye S. Systemic immediate-type reactions to gelatin included in Japanese Encephalitis vaccines. Vaccine 15 (1997) 121-122
18. Singer S., Johnson C.E., Mohr R., and Holowecky C. Urticaria following varicella vaccine associated with gelatin allergy. Vaccine 17 (1999) 327-329
19. Andrews R.M., Kempe A.E., Sin K.K., and Herceg A. Vaccinating children with a history of serious reactions after vaccination or of egg allergy. Med. J. Australia 168 (1998) 491-494
20. Gold M., Goodwin H., Botham S., Burgess M., Nash M., and Kempe A. Revaccination of 421 children with a past history of an adverse reaction in a special immunization service. Arch Dis Child 83 (2000) 128-131
21. Kobayashi RH. Vaccinations. Immunol Allergy Clin N Amer 15 (1995) 553-566
22. Poley G.E., and Slater JE. Drug and vaccine allergy. Immunol Allergy Clin N Amer 19 (1999) 409-422
23. Ponvert C., Scheinmann P., Karila C., Bakonde V.B., Le Bourgeois M., and de Blic J. L'allergie aux vaccins associés chez l'enfant : une étude de 30 cas fondée sur les tests cutanés à lecture immédiate, semi-retardée et retardée, sur les dosages des anticorps spécifiques et sur les injections de rappel. Rev Fr Allergol Immunol Clin 41 (2001) 701-711
24. Ponnighaus J.M., Fine P.E.M., and Moreno C. Hypersensitivity to dextran in BCG vaccine. Lancet 337 (1991) 1039
25. Rudin C., Amacher A., and Berglund A. Anaphylactoid reaction associated with BCG vaccination. Lancet 337 (1991) 377
26. Rudin C., Günthard J., Halter C., Staehelin J., and Berglund A. Anaphylactoid reaction to BCG vaccine containing high molecular weight dextran. Eur J Pediatr 154 (1995) 941-942
27. Fauquert J.L., Tridon A., Labbé A., and Perrier C. Réaction anaphylactoïde post-BCG : le rôle du dextran ?. Rev Fr Allergol Immunol Clin 41 (2001) 412-414
28. Grüber C., and Niggemann B. A practical approach to immunization in atopic children. Allergy 57 (2002) 472-479
29. Ponvert C., and Scheinmann P. Les réactions allergiques et pseudo-allergiques aux vaccins. Rev Fr Allergol Immunol Clin 44 (2004) 461-468
30. Arora S., Sanyal R.K., and West G.B. The sensitizing action of Bordetella pertussis vaccine. Int Arch Allergy Appl Immunol 38 (1970) 357-362
31. Sen D.K., Arora S., Gupta S., and Sanyal R.K. Studies of adrenergic mechanisms in relation to histamine sensitivity in children immunized with Bordetella pertussis vaccine. J Allergy Clin Immunol 54 (1974) 25-31
32. Brouard J., Freymuth F., Toutain F., Vabret A., Petitjean J., Gouarin S., et al. Exacerbations de l'asthme et infection virale associée à celle du Chlamydia pneumoniae et du Mycoplasma pneumoniae : épidémiologie comparative entre nourrissons et enfants âgés de plus de deux ans. Rev Fr Allergol Immunol Clin 41 (2001) 389-395
33. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Brit Med J 310 (1995) 1225-1229
34. Little J.W., Hall W.J., Douglas R.G., Mudholkar G.S., Speers D.M., and Patel K. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Resp Dis 118 (1978) 295-303
35. Thumerelle C., Deschildre A., Bouquillon C., Santos C., Sardet A., Scalbert M., et al. Role of viruses and atypical bacteria in axacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region, France. Pediatr Pulmonol 35 (2003) 75-82
36. Banks J., Bevan C., Fennerty A., Ebden P., Walters E.H., and Smith AP. Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients. Eur J Respir Dis 66 (1985) 268-272
37. de Jongste J.C., Degenhart H.J., Niejens H.J., Duiverman E.J., Raatgeep H.C., and Kerrebijn KF. Bronchial responsiveness and leukocyte reactivity after influenza vaccine in asthmatic patients. Eur J Respir Dis 65 (1984) 196-200
38. Hassan W.U., Henderson A.F., and Keaney N.P. Influenza vaccination in asthma. Lancet 339 (1992) 194
39. Albarraz M.K., Harvey J.E., Grilli E.A., Caul E.D., and Roome A.P. Subunit influenza vaccination in adults with asthma: effect on clinical state, airway reactivity, and antibody response. Brit Med J 294 (1987) 1196-1197
40. American Lung Association of Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 345 (2001) 1529-1536
41. Chin W.J., Kuo M.L., Tsao C.H., Yeh K.W., Yao T.C., et al. Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma. Pediatr Allergy Immunol 14 (2003) 429-436
42. Kramarz P., De Stefano F., Gargiullo P.M., Chen R.T., Lieu T., Davis R.L., et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med 9 (2000) 617-623
43. Murphy K.R., and Strunk R.C. Safe administration of influenza vaccine in asthmatic children allergic to egg proteins. J Pediatr 106 (1985) 931-933
44. Nicholson K.G., Nguyen Van Tam J.S., Ahmed A.H., Wiselka M.J., Leese J., Ayres J., et al. Randomized placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 351 (1998) 326-331
45. Reid D.W., Bromly C.L., Stenton C., Hendrick D.J., and Bourke S.J. A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma. Resp Med 92 (1998) 1010-1011
46. Sener M., Gursel G., and Turktas H. Effects of inactivated influenza vaccination on bronchial reactivity, symptom scores and peak flow variability in patients with asthma. J Asthma 36 (1999) 165-169
47. Watson J.M., Cordier J.F., and Nicholson K.G. Does influenza immunization cause exacerbations of chronic airflow obstruction or asthma. Thorax 52 (1997) 190-194
48. Sugaya N., Nerome K., Ishida M., Matsumoto M., Mitamura K., and Nirasawa M. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. J Am Med Assn 272 (1994) 1122-1126
49. Smits A.J., Hak E., Stalman W.A., van Essen G.A., Hoes A.W., and Verheij T.J. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 128 (2002) 205-211
50. Cates C.J., Jefferson T.O., Bara A.I., and Rowe B.H. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2 (2004) CD 000364
51. Christy C., Aligne C.A., Auinger P., Pulcino T., and Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 89 (2004) 734-735
52. Bueving H.J., Bernsen R.M.D., de Jongste J.C., van Suijlekom-Smit L.W.A., Rimmelzwaan G.F., Osterhaus A.D.M.E., et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 169 (2004) 488-493
53. Vialatte J., and Paupe J. Vaccinations chez l'allergique. In: Paupe J., Scheinmann P., and de Blic J. (Eds). Allergologie Pédiatrique (1994), Flammarion Médecine-Sciences, Paris 564-567
54. Frick O.L. Effect of respiratory and other virus infections on IgE immunoregulation. J Allergy Clin Immunol 5 (1986) 1013-1018
55. Gupta R.K., Bost B.E., Relyveld E., and Siber G.R. Adjuvant properties of aluminium and calcium compounds. In: Powell M.F., and Newman M.F. (Eds). Vaccine design: the subunit and adjuvant approach Vol.3 (1995), Plenum Pub Corp, New York 229-248
56. Tarkowski M., and Gorski P. Increased antiovalbumin levels in mice exposed to formaldehyde. Int Arch Allergy Immunol 106 (1995) 422-424
57. Victoratos P., Yangou M., Avramidis N., and Hadjipetrou L. Regulation of cytokine gene expression by adjuvants in vivo. Clin Exp Immunol 109 (1997) 569-578
58. Hedenskog S., Bjorksten B., Blennow M., Granström G., and Granström M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and a acellular pertussis vaccine. Int Arch Allergy Appl Immunol 89 (1989) 156-161
59. Ryan M., Murphy G., Ryan E., Nilsson L., Shackley F., Gothefors L., et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93 (1998) 1-10
60. Kemp T., Pearce N., Fitzharris P., Crane J., Fergusson D., St George I., et al. Is infant immunization a risk factor for childhood asthma or allergy?. Epidemiology 8 (1997) 678-680
61. Braae Olesen A., Juul S., and Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps or rubella, or measles infection. Acta Derm Venereol 83 (2003) 445-450
62. Ortigas A.P., Butler B., and Leiva L.E. Upregulation of CD40 ligand and IL-4 expression by the 23-valent pneumococcal vaccine in children with recurrent infections. J Allergy Clin Immunol 101 (1998) S15 (Abstr. 65)
63. Aalberse R.C., Danneman A., Van Ree R., and Wahn U. The human IgE response to diphteria/tetanus in vivo is suppressed rather than enhanced by covaccination with B. pertussis. J Allergy Clin Immunol 95 (1995) 361 (Abst. 881)
64. Bernsen R.M.D., de Jongste J.C., and van der Wouden J.C. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur Respir J 22 (2003) 962-964
65. Maitra A., Sherriff A., Griffiths M., and Henderson J. Avon Longitudinal Study of Parents and Children Study Team. Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study. Brit Med J 328 (2004) 925-926
66. Nilsson L., Kjellman N.I.M., and Bjôrkstén B. Allergic disease at the age of 7 years after pertussis vaccination in infancy. Arch Pediatr Adolesc Med 157 (2003) 1184-1189
67. Grüber C., Illi S., Lau S., Nickel R., Forster J., Kamin W., et al. Transient suppression af atopy in early childhood is associated with high vaccination coverage. Pediatrics 111 (2003) e282-e288
68. Aaby P., Shaheen S.O., Heyes C.B., Goudiaby A., Hall A.J., Shiell A.W., et al. Early BCG vaccination and reduction of atopy in Guinea-Bissau. Clin Exp Allergy 30 (2000) 644-650
69. Shirakawa T., Enomoto T., Shimazu S.I., and Hopkin J.M. The inverse association between tuberculin responses and atopic disorders. Science 275 (1997) 77-79
70. Alm J.S., Lilja G., Pershagen G., and Scheynius A. Early BCG vaccination and development of atopy. Lancet 350 (1997) 400-403
71. Annus T., Montgomery S.M., Riikjärv M.A., and Björkstén B. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and age at BCG vaccination. Allergy 59 (2004) 1068-1073
72. Bager P., Rostgaard K., Nielsen N.M., Melbye M., and Westergaard T. Age at bacille Calmette-Guérin vaccination and risk of allergy and asthma. Clin Exp Allergy 33 (2003) 1115-1117
73. Grüber C., Kulig M., Bergmann R., Guggenmoos-Holzmann I., Wahn U, and the MAS-90 Study Group. Delayed hypersensitivity to tuberculin, total IgE, specific sensitization and atopic manifestations in longitudinally followed early BCG-vaccinated children. Pediatrics 107 (2001) e36
74. Marks G.B., Ng K., Zhou J., Toelle B.G., Xuan W., Belousova E.G., et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 111 (2003) 541-549
75. Strannegard I.L., Larsson L.O., and Strannegard O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Science 275 (1998) 77-79
76. McKeever T.M., Lewis S.A., Smith C., and Hubbard R. Vaccination and allergic disease: a birth cohort study. Am J Pub Hlth 94 (2004) 985-989
77. Koppen S., de Groot R., Neijens H.J., Nagelkerke R., van Eden W., and Rümke H.C. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 22 (2004) 3375-3385
78. Ponvert C. Quoi de neuf en allergologie pédiatrique en 2005 ? Partie 1 : épidémiologie, diagnostic précoce et prévention (une revue de la littérature internationale d'octobre 2004 à octobre 2005). Rev Fr Allergol Immunol Clin 46 (2006) 421-435
79. Barnett M.D. Influenza immunization in children. N Engl J Med 338 (1998) 1459-1461
80. Advisatory Committee on immunization practices. General recommandations on immunization: guidelines for the immunization practices. Ann Int Med 111 (1989) 133-142
81. Park C.L., Frank A.L., Sullivan M., Jindal B., and Baxter B.D. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 98 (1986) 196-200